DD209817A5 - Verfahren zur Herstellung von Chinolinderivaten - Google Patents

Verfahren zur Herstellung von Chinolinderivaten Download PDF

Info

Publication number
DD209817A5
DD209817A5 DD25055683A DD25055683A DD209817A5 DD 209817 A5 DD209817 A5 DD 209817A5 DD 25055683 A DD25055683 A DD 25055683A DD 25055683 A DD25055683 A DD 25055683A DD 209817 A5 DD209817 A5 DD 209817A5
Authority
DD
German Democratic Republic
Prior art keywords
carbon atoms
compound
acid
methyl
alkyl
Prior art date
Application number
DD25055683A
Other languages
German (de)
English (en)
Inventor
Count David James Le
Robert James Pearce
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB838302236A external-priority patent/GB8302236D0/en
Application filed by Ici Plc filed Critical Ici Plc
Publication of DD209817A5 publication Critical patent/DD209817A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DD25055683A 1982-05-04 1983-05-03 Verfahren zur Herstellung von Chinolinderivaten DD209817A5 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8212787 1982-05-04
GB838302236A GB8302236D0 (en) 1983-01-27 1983-01-27 Heterocyclic compounds

Publications (1)

Publication Number Publication Date
DD209817A5 true DD209817A5 (de) 1984-05-23

Family

ID=26282723

Family Applications (1)

Application Number Title Priority Date Filing Date
DD25055683A DD209817A5 (de) 1982-05-04 1983-05-03 Verfahren zur Herstellung von Chinolinderivaten

Country Status (13)

Country Link
US (1) US4607039A (enExample)
EP (1) EP0093521B1 (enExample)
KR (1) KR840004726A (enExample)
DD (1) DD209817A5 (enExample)
DE (1) DE3377796D1 (enExample)
DK (1) DK199183A (enExample)
ES (1) ES522089A0 (enExample)
FI (1) FI831537L (enExample)
GB (1) GB8310261D0 (enExample)
GR (1) GR78484B (enExample)
IL (1) IL68513A0 (enExample)
NO (1) NO831562L (enExample)
PT (1) PT76630B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308601D0 (en) * 1983-03-29 1983-05-05 Ici Plc Heterocyclic compounds
JPH064584B2 (ja) * 1984-02-29 1994-01-19 沢井製薬株式会社 新規アニリド誘導体
US5179107A (en) * 1990-09-07 1993-01-12 Schering Corporation Antiviral quinolinone compounds
EP0549729B1 (en) * 1990-09-07 1997-12-17 Schering Corporation Antiviral compounds and antihypertensive compounds
US5190956A (en) * 1990-09-07 1993-03-02 Schering Corporation Certain N-substituted 3-oximino-2,4-dioxoquinolin-2,4-(1H)diones useful for treating viral infections
GB9022785D0 (en) * 1990-10-19 1990-12-05 Merck Sharp & Dohme Therapeutic agents
US5179093A (en) * 1991-05-10 1993-01-12 Schering Corporation Quinoline-diones
US6566361B2 (en) 1999-06-30 2003-05-20 Laboratories, Upsa Azapirone pain treatment
FR2795645B1 (fr) 1999-06-30 2001-09-21 Union Pharma Scient Appl Nouvelle association pharmaceutique a activite analgesique
MY120631A (en) * 2000-09-08 2005-11-30 Union Pharma Scient Appl Novel pharmaceutical combination having analgesic activity
WO2007089634A2 (en) * 2006-01-30 2007-08-09 Merck & Co., Inc. Inhibitors of fatty acid synthase (fas)
US8680116B2 (en) * 2009-07-22 2014-03-25 Merck Sharp & Dohme Corp. Quinolinone PDE2 inhibitors

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US16394A (en) * 1857-01-13 Improvement in gotton-gins
DE430960C (de) * 1924-07-11 1926-06-23 J G Farbenindustrie Akt Ges Verfahren zur Darstellung von basischen AEthern von Chinolinderivaten
US1572768A (en) * 1925-06-26 1926-02-09 Winthrop Chem Co Inc Pharmaceutical product
US1860286A (en) * 1929-05-16 1932-05-24 Soc Of Chemical Ind Basic ethers of aryl-quinolines
GB349761A (en) * 1929-05-16 1931-06-04 Chem Ind Basel Manufacture of aminoalkoxy-derivatives of aryl-quinolines
US4035374A (en) * 1973-05-03 1977-07-12 Smith Kline & French Laboratories Limited Imidazolyl alkylaminopyridone and pyridinethione compounds
US4260764A (en) * 1976-12-22 1981-04-07 Pfizer Inc. 9-Hydroxyoctahydrobenzo [C] quinolines and intermediates therefor
US4343805A (en) * 1978-12-16 1982-08-10 John Wyeth & Brother Limited Heterocyclic compounds
US4235909A (en) * 1979-04-19 1980-11-25 Eli Lilly And Company Octahydro-2H-pyrrolo[3,4-g]quinolines
ES499716A0 (es) * 1980-03-01 1982-05-01 Wyeth John & Brother Ltd Un procedimiento para la preparacion de nuevos derivados de piperidina
IN158970B (enExample) * 1981-06-09 1987-02-28 Ici Plc

Also Published As

Publication number Publication date
FI831537A7 (fi) 1983-11-05
GR78484B (enExample) 1984-09-27
US4607039A (en) 1986-08-19
GB8310261D0 (en) 1983-05-18
DK199183A (da) 1983-11-05
KR840004726A (ko) 1984-10-24
NO831562L (no) 1983-11-07
ES8502093A1 (es) 1984-12-16
PT76630A (en) 1983-06-01
EP0093521A3 (en) 1984-08-01
EP0093521B1 (en) 1988-08-24
IL68513A0 (en) 1983-07-31
FI831537L (fi) 1983-11-05
DK199183D0 (da) 1983-05-04
FI831537A0 (fi) 1983-05-04
EP0093521A2 (en) 1983-11-09
DE3377796D1 (en) 1988-09-29
ES522089A0 (es) 1984-12-16
PT76630B (en) 1985-12-03

Similar Documents

Publication Publication Date Title
Iemura et al. Synthesis of 2-(4-substituted-1-piperazinyl) benzimidazoles as H1-antihistaminic agents
DE3876813T4 (de) 3(2H)Pyridazinon, Verfahren zu dessen Herstellung und dieses enthaltendes Mittel gegen SRS-A.
DD200371A5 (de) Verfahren zur herstellung von 2,4-disubstituierten thiazolen
DE68920797T2 (de) Herzmittel.
DD273833A5 (de) N 9 - cyclopentylsubstituierte adeninderivate
JPS59219260A (ja) 新規なナフタレン−およびアザナフタレン−カルボキサミド誘導体、それを含有する製薬学的組成物、並びにそれらの製造法
EP0005828B1 (de) Neue substituierte Phenylpiperazinderivate, diese enthaltende Arzneimittel und Verfahren zu deren Herstellung
DD209817A5 (de) Verfahren zur Herstellung von Chinolinderivaten
DD263772A5 (de) Verfahren zur herstellung neuer 1h, 3h-pyrrolo[1,2-c]thiazolderivate
DE2727469A1 (de) Neue hexahydropyrimidine, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten
DE69127976T2 (de) Tropolonderivate und pharmazeutische zubereitungen davon zur vorbeugung und behandlung von ischämischen krankheiten
DE69207301T2 (de) Substituierte 3-Piperazinylalkyl 2,3-Dihydro-4H-1,3-Benzoxazin-4-One, deren Herstellung und Verwendung in Heilkunde
JPH0517904B2 (enExample)
DE69232484T2 (de) Hydroisochinolinderivate
DD283996A5 (de) Verfahren zur herstellung von aminoderivaten
DE69523595T2 (de) Aryl und heteroaryl alkoxynaphtalen derivate
DE2334009A1 (de) Purin-derivate sowie verfahren zu ihrer herstellung
DD282457A5 (de) Verfahren zur herstellung neuer heterocyclischer derivate
DE69805033T2 (de) Tetrazolderivate als LTD4 und H1 Antagonisten
DD208801A5 (de) Verfahren zur herstellung von thiomethylpyridin-derivaten
CH637391A5 (de) Therapeutisch wirksame 3-(1-piperazinyl)-1,2,4-benzotriazine und ihre n-oxide.
DD238790A5 (de) Verfahren zur herstellung von 3-amino carbonylmethoxy-5-phenylpyrazol-verbindungen
DE68913167T2 (de) Indol-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate.
US4607040A (en) Quinoline derivatives which are 5-hydroxytryptamine antagonists
DE2257443A1 (de) Neue heterocyclische verbindungen und verfahren zu deren herstellung